Pharmacoperones include the most recent GnRHR therapeutic approaches that directly correct the misfolded GnRHRs, which are caused by genetic mutations and hold serious promise for CHH treatment. This evidence concerns the gene GNRHR and cartilage-hair hypoplasia.